- Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
Lisi Zeng et al, 2022, Frontiers in Oncology CrossRef - A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
Markus W. Löffler et al, 2019, Frontiers in Immunology CrossRef - Radiofrequency Thermal Ablation of Hepatocellular Carcinoma Liver Nodules Can Activate and Enhance Tumor-Specific T-Cell Responses
Alessandro Zerbini et al, 2006, Cancer Research CrossRef - The role of HSP90 molecular chaperones in hepatocellular carcinoma
Masoud Nouri‐Vaskeh et al, 2020, Journal of Cellular Physiology CrossRef - Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems
Jianlan Peng et al, 2024, International Journal of Nanomedicine CrossRef - Recent Advances in Thermal Treatment Techniques and Thermally Induced Immune Responses Against Cancer
J. F. Bai et al, 2014, IEEE Transactions on Biomedical Engineering CrossRef - Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights
Maria Tampaki, 2015, World Journal of Hepatology CrossRef - CEUS-Based Radiomics Can Show Changes in Protein Levels in Liver Metastases After Incomplete Thermal Ablation
Haiwei Bao et al, 2021, Frontiers in Oncology CrossRef - Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Cheng Zhong et al, 2021, Frontiers in Oncology CrossRef - Silica-Coated Metal Chelating-Melanin Nanoparticles as a Dual-Modal Contrast Enhancement Imaging and Therapeutic Agent
Soojeong Cho et al, 2017, ACS Applied Materials & Interfaces CrossRef - Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials
Minhan Jiang et al, 2023, Frontiers in Oncology CrossRef - Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma
Yang Zhao et al, 2024, Frontiers in Immunology CrossRef - The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy
Yuxin Duan et al, 2023, BioScience Trends CrossRef